of the immune system, diabetes mellitus, HIV positivity, malignancy, chronic steroid usage, renal failure, septicemia, recent spinal surgery, and intravascular devices. 2 Vertebral infection has remained a challenging problem despite advances in medical knowledge, imaging techniques, and surgical spine instrumentation. 8 There is no consensus regarding its optimal management or the optimal duration of parenteral antibiotic therapy and of subsequent oral therapy. 13 Furthermore, questions remain regarding whether and when to obtain tissue cultures from the infected vertebra in cases in which blood cultures are positive, since it is known that the latter are accurate in identification of the pathogen involved in the spinal infection in approximately 85% of cases. 14, 15 Nevertheless, in the majority of cases of primary spinal infections, conservative management of infection with antibiotic therapy is successful. 5 However, in a minority of cases, surgical intervention is warranted.
As mentioned above, one of the main reasons for the increase in the incidence of spinal infections is thought to be the increase in the rate of recreational drug abuse. Unfortunately, diagnosis and treatment of these pathological conditions in this population is challenging. Many of these patients experience irreversible neurological deficits due to their late presentation for medical attention, the lack of adequate follow-up, continuation of their drug abuse habits, and the need for prolonged hospitalization to prevent them from using the intravenous access devices other than for antibiotic injection. 19 It is estimated that the mean annual health cost per IVDA patient diagnosed with soft-tissue or skeletal infection is CAD$119,574. 19 Unfortunately, protocols for diagnosis and management of spine infections in the IVDA population are lacking.
Here we retrospectively reviewed 102 cases of primary spine infection in patients with a history of IVDA. The purpose of our review was to define the contemporary trends in etiology, concomitant risk factors, presentation, and management of spine infection in this patient population. Additionally, we determine factors leading to surgical intervention and describe the outcomes.
Methods
We initially identified all cases involving patients evaluated in our institution (University Hospital, San Antonio, Texas) for spine infection during the period from August 2005 through December 2013. From these cases, those involving pyogenic spinal infection in patients with a history of recreational IVDA were selected for this retrospective review. All cases of postsurgical wound infection, so-called secondary spine infection, were excluded, unless the first surgical intervention was performed for spine infection. The data extracted from the electronic medical records of University Hospital and the neurosurgery department database included patient age, sex, site of infection, concomitant diseases, risk factors, preceding events, clinical presentation, laboratory values, treatment modalities, surgical indications, type of procedure performed, and outcomes. The following laboratory data were reviewed: erythrocyte sedimentation rate (ESR), white blood cell (WBC) count, and C-reactive protein (CRP) level. Microbiological results from blood, urine, and spine biopsy cultures as well as any other tissue cultures were reviewed. Radiological studies reviewed included information from plain radiographs, CT, and MRI on admission and follow-up.
Diagnosis was made on the basis of a combination of clinical history, physical examination findings, results of radiological assessment, and positive organism cultures. As previously described, 2 diagnosis of spinal infection was additionally given in cases with suggestive clinical features and appropriate radiological changes, in which microbial cultures remained negative, but the patients had elevated inflammatory markers and/or responded favorably to antimicrobial therapy. All surgical reports for the surgically treated patients were reviewed with emphasis on the type of approach, need for reoperation, and the number of levels instrumented.
This study was approved by the institutional review board of the University of Texas Health Science Center at San Antonio and University Hospital in San Antonio, Texas.
Results

Demographics
One hundred sixty-four patients with primary pyogenic spinal infection were treated at our institution between August 2005 and December 2013. From these, 102 patients (62%) with a history of remote or current recreational IVDA were identified. Most of the patients were male (87 men [85.3%], 14 women [13.7%], ratio of 5.8:1). Their mean age at presentation was 45.4 years, with the majority being in the 41-to 60-year-old age group (range 22-66 years) ( Table 1) .
Diagnosis and Presentation
All 102 patients presented with persistent neck or back pain, depending on the level of the disease. MRI showed findings consistent with spondylodiscitis with or without epidural abscess, exclusive epidural abscess, or spondylodiscitis expanding into the surrounding paravertebral soft tissue. Seven patients (6.9%) presented with epidural abscess alone, 19 (18.6%) presented with epidural abscess associated with spondylodiscitis, and 76 (74.5%) presented with spondylodiscitis without epidural abscess (see Table 5 ). Patients who presented with epidural abscess (n = 26) were more likely to present with some degree of neurological deficits. In 1 case, the patient's impairment was classified as Grade A on the American Spinal Injury Association (ASIA) Impairment Scale (AIS), in 1 case as Grade B, in 3 cases as Grade C, and in 3 other cases as Grade D. In the 18 other cases, the AIS grade was E (no impairment).
Other Comorbidities
Thirty-four patents presenting with spinal infection had concomitant hepatitis C, 1 patient had HIV infection, and 2 patients had coexistent HIV and hepatitis C. Eight patients were diagnosed with endocarditis, 7 were diagnosed with with diabetes mellitus, and 12 admitted alcohol abuse ( Table 2 ). Nine patients admitted remote IV drug abuse (3-20 years previously) but also admitted recent use of recreational drugs via other routes and had other comorbidities, including alcohol abuse (3 patients), hepatitis C (3 patients), diabetes mellitus (1), and lymphoma (1). Of these patients one had experienced a recent fall; another was involved in a motor vehicle accident; 5 patients had undergone recent surgical procedures for dental pathology (2 patients), colon cancer (1), or splenectomy after traumatic injury (1) or ankle injections for ankle pain (1); and 2 patients had undergone remote back surgery (4 years earlier).
Laboratory Data
The average WBC count at presentation was 11.1 × 10 3 cells/ml (range 0.5-32 × 10 3 cells/ml; normal range 5.5-11 × 10 3 cells/ml). The WBC count was in the normal range in 52 patients (51%), while 2 patients presented with leukopenia (< 5.5 × 10 3 cells/ml). The mean erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels at presentation were 74 mm/hr (range 9.9-140 mm/hr) and 67 mg/L (range 0.1-323 mg/L), respectively. Laboratory values showed that 9 patients (8.8%) presented with normal ESR (< 9.9 mm/hour) and 30 (29%) presented with normal CRP (< 0.1 mg/L) ( Table 1) . Due to the suboptimal compliance with follow-up visits, we were able to track the normalization of the inflammatory markers in only 44 of the 73 patients who had abnormal values at initial presentation. The average number of days from presentation with abnormal inflammatory markers to their normalization after treatment in these patients was 44.8 days (range 6-130 days).
In 40 cases (39.2%) methicillin-sensitive Staphylococcus aureus (MSSA) grew in the culture media, while methicillin-resistant S. aureus (MRSA) grew in 23 (22.5%). Only 4 patients had Pseudomonas aeruginosa isolated from the tissue of their bone biopsy. Ten patients had no growth on their cultures from either a peripheral source or bone biopsy (Table 3) .
Spinal Level Distribution
The most commonly affected levels were lumbar (59 patients [57.8%]), followed by thoracic (24 [23.5%]) and cervical (9 [8.8%]). The remaining patients had infections spanning either in the cervicothoracic junction or the thoracolumbar junction. A single level was involved in 71 patients (69.6%), with the rest having involvement of multiple levels ( Table 4) .
The regional distribution of epidural abscesses is shown in Table 4 . In 3 patients, epidural abscess expanded in multiple spine regions, involving cervicothoracic or thoracolumbar areas. The length of the epidural abscess in different patients ranged from 15 mm to 186 mm, and the width within the spinal canal ranged from 4.2 mm to 13.8 mm.
Medical Treatment
Eighty patients (78.4%) underwent medical treatment with intravenous antibiotic therapy tailored to their specific organism for 6 to 8 weeks. If no organism was identified in cultures, a 6-week course of broad-spectrum empirical antibiotic coverage was prescribed. Of the 7 patients with epidural abscess alone, only 2 (29%) underwent medical treatment alone; the other 5 (71%) underwent surgical intervention (Table 5) . Of those 2 patients, 1 presented without neurological deficit (ASIA E) and the other refused surgical intervention. Twelve (63.2%) of the 19 patients with epidural abscess associated with spondylodiscitis underwent medical treatment alone, and the rest underwent surgical intervention followed by antibiotic therapy.
Surgical Treatment
Twenty-four patients (23.5%) required surgical intervention, 22 at presentation for acute neurological deficits, open biopsy, or spinal deformity and 2 after failure of medical therapy (Fig. 1) . Eight patients (36.3%) underwent laminectomy alone for epidural abscess, 6 underwent open biopsy, 7 underwent anterior vertebrectomy with either anterior instrumentation alone or combined anterior and posterior instrumentation, and 3 underwent laminectomy and posterior instrumentation. Five of the 7 patients who presented with epidural abscess alone underwent laminectomy or laminotomy because of presentation with acute neurological deficit.
Follow-Up and Outcome
The average duration of follow-up for the patients who underwent intervention was 29.7 weeks (range 6 weeks-3 years). Follow-up evaluation at 6 weeks after initiation of treatment was performed in 83 cases (81%). The 83 patients in these cases all remained in the hospital for the entire duration of the IV antibiotic treatment. At 3 months, 79 patients (78%) presented at the follow-up visits; at 12 months, 72 patients (70.5%); and only 66 (64.7%) presented for follow-up visits at their primary care physician's office after the 1-year mark (up to 3 years) ( Table   6 ). The infectious diseases consultant evaluated all patients, and their course was followed with clinical assessment and serial laboratory tests (ESR and/or CRP level) if they presented for follow-up and had shown elevated inflammatory markers at initial presentation. Due to the accepted concept that follow-up imaging is not warranted in all patients because improvement of the MRI appearance lags behind improvement in clinical presentation, 3, 9 we reserved imaging studies for patients who did not demonstrate clinical improvement.
Two patients who had previously undergone surgical intervention presented with osteomyelitis at the adjacent levels and required reoperation with extension of the arthrodesis and posterior instrumentation. Both of these patients had continued their IVDA habits. Three patients had superficial wound infections; 2 were treated with wound care and a new course of IV antibiotic therapy, and 1 underwent surgical debridement. A significant number of patients in our cohort had multiple "no-show" appointments. In the nonsurgically managed group the average duration of follow-up was 6 months. None of the patients had worsening of their neurological condition during the follow-up period. Two patients who required surgical intervention due to failure of medical therapy presented with increased back pain (Fig. 1) . Neither of these patients had epidural abscess at first presentation.
Discussion
Although recreational IVDA is thought to be one of the major factors in the recent increase in the incidence of spinal infection, very few reports have described exclusively this in the literature. Sapico and Montgomerie 18 reported 3 cases of spine infection in IVDA patients and identified 64 other cases reported in the literature. They found that the majority of patients had lumbar spine involvement (53.5%) and with respect to causative agents reported that the 65.5% of all isolates were Pseudomonas (labeled "Pseudomonas species" or P. aeruginosa). Chuo et al. 5 reported 21 cases of spine infection in IV drug abusers, with 19 suffering from pyogenic spine infection. Wang and colleagues have reported the only prospective study performed to date where diagnosis, management, and outcome of 51 patients with spinal infection and IVDA was compared with a cohort of patients with spinal infection without recreational IV drug use. 19 We report here on a cohort of 102 consecutive recreational patients with a history of IVDA who were treated for spinal infection at our hospital. To our knowledge, ours is the largest series of patients with spine infection and IVDA as the major risk factor. The majority of our patients were male, aged 41-60 years, and had predominantly lumbar localization (57.8%), similar to the findings of Sapico and Montgomerie 18 and Chuo et al. 5 Our data, however, differ from the finding of Wang et al., who reported predominantly cervical spine involvement. 19 The difference for these findings could be explained by the location of injection in the cases reported by Wang and colleagues, whose patients used jugular veins more frequently.
Illicit drug abuse is a worldwide health problem. Approximately 5% of the global population (200 million people) use illicit drugs. 6 It has been reported that there are an estimated 13 million injection-drug users worldwide, 78% of whom live in developing countries.
6
Unfortunately infections, such as HIV, viral hepatitis, and various bacterial infections, are among the most serious complications of IV drug use. According to a review by Gordon and Lowy, 6 most bacterial infections in this population are caused by the individual's own commensal flora, with S. aureus and Streptococcus species being the most common pathogens isolated. Infection by organisms such as P. aeruginosa indicates that a specific drug or drug-use behavior is involved. 6 In agreement with the findings of Chuo et al. 5 and Wang et al., 19 we found that in the majority of our patients, the causative organisms was S. aureus-MSSA in 39.2% and MRSA in 22.5% of the patients (Table 2) . Pseudomonas aeruginosa was found only in 4 patients (3.9%) in our series, a finding that contrasts with that of Sapico and Montgomerie who determined that Pseudomonas species were isolated in 65.5% of the 64 cases they identified in their literature review. 18 Musculoskeletal infections generally result from hematogenous seeding or local extension of a skin or softtissue infection in drug users. These infections may be indolent, with the only symptom being pain without fever.
All of our 102 patients had severe back and/or neck pain at presentation, suggesting that a history of recent or remote recreational IVDA associated with back pain should prompt further diagnostic workup, preferably MRI with and without contrast, to exclude spinal infection even in the absence of fever and abnormal WBC count.
In the IVDA population, in contrast to the general population, diabetes mellitus does not appear to be a factor that predisposes patients to primary pyogenic spinal infection. Only 7 patients (6.9%) in our population had diabetes mellitus. Hepatitis C positivity was found in 34 patients (33%), hepatitis B in 2, and HIV in 3 patients. We have to consider that the nonsterile practice of use of needles for drug injection and needle interchange with other individuals predisposes these patients to multiple infectious agents. Endocarditis was found in only 8 patients, suggesting that hematogenous seeding of bacteria in the spine is not related to the presence of endocarditis and septic emboli.
The diagnosis of spinal infection in patients with neck or back pain and a history of IVDA requires a high index of suspicion. The experience from our institution shows that routine laboratory tests are poor markers for this diagnosis. The WBC counts were elevated on admission in only 49% of our patients; ESR and CRP levels (inflammatory markers) were increased in 91% and 71% of the patients, respectively. These laboratory values-if abnormal-were sensitive indicators of the disease progression or regression during treatment (data not shown), although they are not specific for initial diagnosis of spine infection in IVDA patients. Figure 2 presents the management flowchart developed and applied in our institution. When a patient with back pain and a history of IVDA presents to our hospital, an MRI study with and without contrast is requested, and if spinal infection is suspected from the MRI findings, infection disease specialists and spine surgeons are consulted. At the same time laboratory evaluation of WBC count, ESR, and CRP level is performed in conjunction with blood and urine cultures. The patient is furthermore evaluated for the presence of any other site of infection. Two patients in our cohort were found to have other joint infections, one in a hip and the other in a knee joint.
All our patients undergo a full evaluation by infection disease specialists to find the source and/or other sites of infection. All patients are initially treated with antibiotic therapy based on culture results for a duration of 6 to 8 weeks. In cases in which surgical intervention is not indicated, image-guided biopsy of the suspicious spine lesion is performed. Surgical intervention is considered only in the event of medical therapy failure revealed by progression of the spine deformity, new neurological deficit or progression of old neurological deficits, persistent or worsening pain, and persistent elevation of CRP and ESR values, in combination with worsening of findings on MRI, and when image-guided needle biopsy is negative.
The main pillar for treatment of spine infection even in the IVDA population remains antibiotic therapy, as in the non-IVDA population. Only 24 of our patients underwent a surgical procedure. The other 78 patients (76%) in our series were treated exclusively with IV antibiotic therapy, and over a mean follow-up period of 6 months they showed improvement of back and/or neck pain and neurological status, confirming that surgical intervention is needed only in selected cases. This approach is in line with what others have suggested in the literature.
7,17 Patients with acute neurological deficits secondary to the lesion found in the MRI and those with newly diagnosed spine deformity caused by spondylodiscitis are considered for surgical intervention. Resai and colleagues 17 have suggested that patients with kyphotic deformity of more than 11° in the cervical spine or 20° in the thoracolumbar spine should be considered for surgical intervention and deformity correction. They caution, however, that these suggestions are extrapolated from guidelines for instability in spine trauma because such studies for kyphosis in spine infection do not exist.
17
Regarding the presence of epidural abscess, 5 of the 7 patients who underwent surgical decompression presented with acute neurological deficits. In our cohort, 26 patients presented with epidural abscess alone (7 patients) or in association with spondylodiscitis (19 patients). Only 12 patients (46%) from this group underwent surgical intervention followed by antibiotic therapy, 8 due to acute neurological deficit (AIS Grade A, B, C, or D at presentation) and 4 others due to spondylodiscitis induced spinal deformity (AIS Grade E at presentation). The other 14 patients with epidural abscess and/or spondylodiscitis without acute neurological deficit or spinal deformity were treated with antibiotic therapy alone. Our data suggest that antibiotic therapy alone should be considered as the first line of treatment in patients with epidural abscess without acute neurological deficit and/or severe spinal deformity and that in those patients, epidural abscess should not be considered a neurosurgical emergency.
Although our patients' compliance was not optimal, we believe that 71% follow-up compliance at 1 year is an acceptable value for this patient population. Failure of antibiotic therapy was seen in only 2 patients (1.9%) treated with antibiotics alone and 2 other patients treated with surgical intervention followed by antimicrobial therapy. None of the patients who had epidural abscess and were treated with medical therapy alone developed any new neurological deficit or spinal deformity while under treatment. Nevertheless, we recommend caution in interpreting these data due to the suboptimal long-term follow-up rate.
In our series of 102 patients, the patients who underwent surgical intervention did so mainly for progressive kyphosis while on antibiotic therapy, acute neurological deficits secondary to epidural abscess, or newly diagnosed severe infection-induced kyphotic deformity at presentation.
Conclusions
The treatment of spinal infection in the IVDA population is difficult and further complicated by the fact that many of these patients will continue to use recreational drugs even after diagnosis has been made and the treatment has been started. Furthermore, this patient population has shown to be noncompliant with treatment protocols and follow-up. Their discharge from the hospital is complicated by the concern for their safety as the IV access used for long-term antibiotic therapy could be abused for drug self-injection. We conclude that any patient with a history of IVDA presenting with back pain should undergo imaging (preferably MRI with and without contrast) to evaluate for a possible spine infection even when the results of laboratory tests for inflammatory parameters are within the normal range. The majority of these patients can be effectively treated with antibiotics alone, with surgical intervention being necessary only in a minority of cases.
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